Erazaban (Erasaban) cream 10% 2gr

User manual for Erazaban

Reed more and buy Erasaban on this page

Composition

1 g of cream contains:
Active substances: docosanol 100 mg.
Excipients: sucrose 50 mg, mineral oil 80 mg, propylene glycol 50 mg, benzyl alcohol 27 mg, water 693 mg.
Packaging
Tuba 2

pharmachologic effect

Pharmacodynamics

Docosanol is an antiviral agent. In vitro studies have shown that docosanol affects the adhesion of the virus to the plasma membrane, which inhibits the penetration of the virus into the cell and its replication. This mechanism of action makes it unlikely that the Herpes simplex strains resistant to the antiviral effects of docosanol will appear, but also protects against the penetration of the virus into healthy cells. In vitro studies have shown that cells treated with docosanol are resistant to infections caused by lipid-membrane viruses, such as the first type of Herpes simplex virus.

Pharmacokinetics

When applied externally, Erazaban is practically not subjected to systemic absorption. Docosanol is metabolized intracellularly to docosanoic acid (the main metabolite). Docosanol and its metabolite are endogenous components of cell membranes in humans. When applying the cream on intact (healthy) skin: the absorption is minimal, not detected in the blood. When applied to affected skin: moderate absorption. Excreted by the kidneys.

Indications

Erasaban, indications for use
Infections of the skin and mucous membranes caused by the Herpes simplex type 1 virus (including herpes lips).

Contraindications

    Hypersensitivity to docosanol or any other component of the drug;
    age up to 12 years (there is no experience of use).
With care: pregnancy and lactation.

Dosage and administration

Outwardly. Erazaban is recommended to be applied 5 times a day (approximately every 3 hours in the daytime) as early as possible after the start of infection, applied in a thin layer on the affected skin areas bordering them. The average healing time is 4 days.
The cream is applied either with a cotton swab or with clean hands to avoid further infection of the affected areas.
The effectiveness of the therapy depends on the time of initiation of therapy: the earlier the onset of the onset of symptoms of the disease, the patience is started, the higher the efficiency. In the case of the start of treatment of a recurrent infection during the prodromal phase or at the very beginning, the preparation Erasaban prevents the appearance of bubble eruptions and the formation of crusts. If the bubbles have already appeared, it reduces swelling and pain, after 2 days the pain, burning, itching, tingling disappear, the visible herpetic manifestations are reduced significantly - bubbles on the lips or on the skin at the site of injury.
It is necessary to conduct a full course of therapy for 5 days, in order to achieve the greatest effect from the patient, even if the signs of infection disappear after 1-2 days of treatment. In the absence of healing, treatment can be continued for up to 10 days.
Dose adjustment in elderly patients and in patients with impaired renal function is not required.

Use during pregnancy and lactation

Experimental studies did not reveal teratogenic and embryotoxic effects on the fetus.
Before using the drug Erazaban during pregnancy or the breastfeeding period, it is necessary to consult a doctor.

Side effects of Erasaban

Headache, dry skin, itching, rash, short-term redness, soreness, peeling, burning or tingling in the application areas. These side effects, as a rule, do not require discontinuation of Erazaban.
There are isolated reports of cases of angioedema during external use of the drug.
If any of the side effects indicated in the instruction are aggravated, or you have noticed any other side effects not indicated in the instruction, inform your doctor.

special instructions for Erasaban

The drug Erasaban is intended for external use only!
Avoid contact with eyes and do not apply to the skin near the eyes. To achieve the maximum therapeutic effect, it is necessary to use Erazaban at the first signs of the disease (burning, itching, tingling, feeling of tension and redness).
If the symptoms persist for more than 10 days, you should consult a doctor.

Influence on the ability to drive vehicles and other mechanisms that require high concentration of attention

Does not affect.

Interaction

When applied externally, no interaction with other drugs was detected.
The increased effect is noted with the simultaneous appointment of immunostimulants.

Overdose

No cases of drug overdose have been reported.
Shelf life - 3 years. After the first opening, store no more than 6 months.

Storage conditions

Store at a temperature not higher than 25 ° С.
Keep out of the reach of children.

Terms of sell

You don't need a prescription to buy Erazaban.